20273 results for «»
20273 results
Simple guidance for the management of valvular heart disease patients in the context of the Covid-19 pandemic
08 Apr 2020
Find out how to manage patients with valvular heart disease in the context of COVID-19
Patients with symptomatic valvular heart disease requiring intervention are at high-risk of severe evolution in case of COVID-19 infection.
Strict individual protective measures are advised. The heart team discussion is key regarding individual...
PCR Spotlight: simple guidance for the management of valvular heart disease patients in the context of COVID-19
16 Apr 2020
In this short video Didier Tchetche and Nicolas Dumonteil provide simple guidance for the management of VHD patients.
ISCHEMIA trial : what's new for stable ischemic heart disease patients ?
09 Apr 2020
The ISCHEMIA trial was designed to evaluate the clinical impact of systematic invasive management in patients with stable ischemic heart disease and significant inducible ischemia. Read this review by guest expert reviewers Francesco Burzotta and Carlo Trani.
Reviewer
Reviewer
PCR on Call
09 Apr 2020
Online case discussions, also available on replay
PCR on Call is one of many initiatives of the Facing COVID-19 with PCR platform, and provides a valuable opportunity to learn from the experience of your peers from across the globe.
Every week, the case of an individual patient is...
PCR on Call: management of inferior STEMI in a COVID-19 patient
12 Apr 2020
In this video, Elad Maor, Flavio Ribichini and William Wijns discuss the case of an immunosuppressed COVID (+) patient with hypertension, scleroderma and acute dizziness.
ISCHEMIA: balancing the risks and benefits of invasive procedures in stable ischemic heart disease patients
16 Apr 2020
In this expert interview, Dejan Milasinovic asks Francesco Burzotta to provide his take on the ISCHEMIA trial.
Author
Author
PCR Planet : the impact of COVID-19 shared by interventional cardiologists from around the world
14 Apr 2020
Discover short informal interviews where PCR Family members discuss the consequences of COVID-19 for the practice of interventional cardiovascular medicine in each of their world regions.
PCR on Call: Late STEMI presentation during COVID-19 outbreak
17 Apr 2020
N. Dumonteil, B. Farah and O. Wendler discuss the case of a patient presenting with late inferior STEMI with RCA PCI, transferred because of ventricular septal rupture.
PCR Spotlight: STEMI management in the context of Covid-19: Thrombolysis
21 Apr 2020
Interventional Cardiologists A. Baumbach, UK, G. Stefanini, Italy, and C. Kyriakakis, South Africa, discuss the use of thrombolysis as an alternative option for STEMI..
PCR Spotlight
14 Apr 2020
Learn from the experience of peers
5 to 7-minute interviews cover specific questions on topics such as team organisation, staff protection, cathlab preparation, and best practice for patient safety during the outbreak.
The utility of rapid atrial pacing immediately post-TAVR to predict the need for pacemaker implantation
04 May 2020
The investigators proposed rapid atrial pacing (RAP) to further risk-stratify patients for post-TAVR PPI. Atrial pacing can be easily performed during the TAVR procedure since a temporary pacemaker (TPM) is routinely positioned in the right ventricle during valve implantation.
Reviewer
Multi- vs culprit-vessel percutaneous coronary intervention in cardiogenic shock
04 May 2020
This study compares outcomes of patients enrolled in the National Cardiogenic Shock Initiative (NCSI) registry treated using a strategy of MV-PCI vs CV-PCI and examines outcomes in patients treated with early MCS.
Reviewer
PCR Planet: interventional cardiology in the context of COVID-19 in Argentina and the USA
28 May 2020
A. Ferrero, Argentina, and J. Granada, USA, discuss the challenges of practising cardiology in the context of the COVID-19 pandemic with B. Prendergast.
Portico with FlexNav TAVI system: enhancing innovative technology to optimize patient outcomes and physician experience
05 May 2020
Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.
Hung Ly Quoc
Montreal, Canada
A controlled trial of rivaroxaban after transcatheter aortic-valve replacement (GALILEO)
13 Dec 2019
The GALILEO trial was a randomized, open-label, event-driven, international, multicentre trial comparing two different preventive strategies for thromboembolic complications in patients who underwent successful TAVI and had not established indication for oral anticoagulation.
Reviewer
Reviewer
Eduardo Bahena-López
Mexico City, Mexico
Mark Roland de Jong
Viviana Mello Guzzo Lemke
Brazil
Makoto Watanabe
Kashihara, Nara, Japan